1-3 of 3
G Vogelsang
Close
Sort by
Journal Articles

Feasibility and Reproducibility of the NIH Consensus Criteria To Evaluate Response in Chronic Graft Versus Host Disease (cGvHD).

S. Mitchell, CRNP, D. Jacobsohn, MD, K. Thormann, CRNP, E. Cowen, MD, J. Fall-Dickson, PhD, M. Turner, MD, M. Schubert, DDS, K. Baird, MD, J. Bolanos-Meade, MD, K. Boyd, DDS, L. Gerber, MD, J.P. Guadagnini, DDS, M. Higman, MD, M. Imanguli, DDS, L. Lawley, MD, L. Li, MD, O. Prachenko, MA, B. Reeve, PhD, J. Smith, MD, G. Vogelsang, MD, S. Pavletic, MD
Journal: Blood
Blood (2006) 108 (11): 5344.
https://doi.org/10.1182/blood.V108.11.5344.5344
Published: 2006
Journal Articles

Feasibility and Reproducibility of the New NIH Consensus Criteria To Evaluate Response in Chronic GvHD - A Pilot Study.

S. Mitchell, CRNP, B. Reeve, PhD, E. Cowen, MD, J. Fall-Dickson, PhD, L. Gerber, MD, J.P. Guadagnini, DDS, M. Robinson, MD, M. Turner, MD, G. Willis, PhD, M. Schubert, DDS, J. Bolanos-Meade, MD, M. Higman, MD, D. Jacobsohn, MD, K. Thormann, CRNP, G. Vogelsang, MD, S. Pavletic, MD
Journal: Blood
Blood (2005) 106 (11): 3121.
https://doi.org/10.1182/blood.V106.11.3121.3121
Published: 2005
Journal Articles

5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens

GJ Dover, S Charache, SH Boyer, G Vogelsang, M Moyer
Journal: Blood
Blood (1985) 66 (3): 527–532.
https://doi.org/10.1182/blood.V66.3.527.527
Published: 1985